智通财经APP讯,瑞科生物-B(02179)发布公告,已于2026年4月29日完成将合共1.42亿股未上市股份转换为H股,而转换后H股于2026年4月30日上午九时正于联交所开始上市。
智通财经APP讯,瑞科生物-B(02179)发布公告,已于2026年4月29日完成将合共1.42亿股未上市股份转换为H股,而转换后H股于2026年4月30日上午九时正于联交所开始上市。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.